Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: A phase 1b, randomised, double-blind, placebo-controlled clinical trial

Hannah Kibuuka, Nina M. Berkowitz, Monica Millard, Mary E. Enama, Allan Tindikahwa, Arthur B. Sekiziyivu, Pamela Costner, Sandra Sitar, Deline Glover, Zonghui Hu, Gyan Joshi, Daphne Stanley, Meghan Kunchai, Leigh Anne Eller, Robert T. Bailer, Richard A. Koup, Gary J. Nabel, John R. Mascola, Nancy J. Sullivan, Barney S. GrahamMario Roederer, Nelson L. Michael, Merlin L. Robb, Julie E. Ledgerwood

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: A phase 1b, randomised, double-blind, placebo-controlled clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences